Literature DB >> 8071432

Activation of the hypothalamic-pituitary-adrenal axis differentially affects the anti-mycobacterial activity of macrophages from BCG-resistant and susceptible mice.

D H Brown1, B S Zwilling.   

Abstract

The effect of hypothalamic-pituitary-adrenal (HPA) axis activation and exogenous glucocorticoids on the ability of splenic macrophages to control the growth of Mycobacterium avium was evaluated. We found that activation of the HPA axis by restraint stress or the addition of corticosterone increased the susceptibility of macrophages from mice that are innately susceptible to the in vivo growth of M. avium. In contrast, the ability of macrophages from innately resistant, congenic mice to control the growth of M. avium was not affected by HPA activation or the addition of corticosterone. The effect of restraint and of corticosterone on macrophage function was abrogated by either treating mice with the glucocorticoid receptor antagonist RU486 or the addition of the drug to cultures of macrophages. Activation of the HPA axis as well as the addition of corticosterone to cultures of macrophages resulted in a suppression of the production of tumor necrosis factor (TNF)-alpha and of reactive nitrogen intermediates by macrophages from both strains of mice. The lack of effect of HPA activation and of corticosterone on the mycobacterial resistance of macrophages from BCG-resistant mice, while at the same time suppressing the production of reactive nitrogen intermediates, appears to rule out a role for this antimicrobial pathway in innate resistance to mycobacterial growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071432     DOI: 10.1016/0165-5728(94)90028-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

1.  Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines.

Authors:  A D Howard; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  Nramp1 is expressed in neurons and is associated with behavioural and immune responses to stress.

Authors:  C A Evans; M S Harbuz; T Ostenfeld; A Norrish; J M Blackwell
Journal:  Neurogenetics       Date:  2001-03       Impact factor: 2.660

Review 3.  Antimicrobial anxiety: the impact of stress on antimicrobial immunity.

Authors:  Katherine A Radek
Journal:  J Leukoc Biol       Date:  2010-05-04       Impact factor: 4.962

4.  Phenotypic changes in T cell populations during the reactivation of tuberculosis in mice.

Authors:  A D Howard; O J Trask; S E Weisbrode; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 5.  The short-term stress response - Mother nature's mechanism for enhancing protection and performance under conditions of threat, challenge, and opportunity.

Authors:  Firdaus S Dhabhar
Journal:  Front Neuroendocrinol       Date:  2018-03-26       Impact factor: 8.606

Review 6.  Effects of stress on immune function: the good, the bad, and the beautiful.

Authors:  Firdaus S Dhabhar
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

7.  Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages.

Authors:  G F Zhu; C Chancellor-Freeland; A S Berman; R Kage; S E Leeman; D I Beller; P H Black
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

8.  Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection versus Immunopathology.

Authors:  Firdaus S Dhabhar
Journal:  Allergy Asthma Clin Immunol       Date:  2008-03-15       Impact factor: 3.406

9.  Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation.

Authors:  D H Brown; B A Miles; B S Zwilling
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 10.  Inflammation and neuropeptides: the connection in diabetic wound healing.

Authors:  Leena Pradhan; Christoph Nabzdyk; Nicholas D Andersen; Frank W LoGerfo; Aristidis Veves
Journal:  Expert Rev Mol Med       Date:  2009-01-13       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.